Literature DB >> 16202589

Structure-based discovery of a new class of Hsp90 inhibitors.

Xavier Barril1, Paul Brough, Martin Drysdale, Roderick E Hubbard, Andrew Massey, Allan Surgenor, Lisa Wright.   

Abstract

Docking-based virtual screening identified 1-(2-phenol)-2-naphthol compounds as a new class of Hsp90 inhibitors of low to sub-micromolar potency. Here we report the binding affinities and cellular activities of several members of this class. A high resolution crystal structure of the most potent compound reveals its binding mode in the ATP binding site of Hsp90, providing a rationale for the observed activity of the series and suggesting strategies for developing compounds with improved properties.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202589     DOI: 10.1016/j.bmcl.2005.08.092

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

Review 2.  The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.

Authors:  Kristoffer R Brandvold; Richard I Morimoto
Journal:  J Mol Biol       Date:  2015-05-21       Impact factor: 5.469

3.  Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitors.

Authors:  Mahmoud A Al-Sha'er; Mutasem O Taha
Journal:  J Mol Model       Date:  2012-06-16       Impact factor: 1.810

4.  Regulation of calreticulin-major histocompatibility complex (MHC) class I interactions by ATP.

Authors:  Sanjeeva Joseph Wijeyesakere; Jessica K Gagnon; Karunesh Arora; Charles L Brooks; Malini Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-29       Impact factor: 11.205

5.  Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides: heat shock protein 90 (Hsp90) inhibitors with submicromolar activity in an in vitro assay.

Authors:  Thota Ganesh; Pahk Thepchatri; Lian Li; Yuhong Du; Haian Fu; James P Snyder; Aiming Sun
Journal:  Bioorg Med Chem Lett       Date:  2008-08-14       Impact factor: 2.823

6.  Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling.

Authors:  Thota Ganesh; Jaeki Min; Pahk Thepchatri; Yuhong Du; Lian Li; Iestyn Lewis; Larry Wilson; Haian Fu; Gabriela Chiosis; Raymond Dingledine; Dennis Liotta; James P Snyder; Aiming Sun
Journal:  Bioorg Med Chem       Date:  2008-05-27       Impact factor: 3.641

Review 7.  Docking screens: right for the right reasons?

Authors:  Peter Kolb; John J Irwin
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

8.  Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthoquinone scaffold.

Authors:  M Kyle Hadden; Stephanie A Hill; Jason Davenport; Robert L Matts; Brian S J Blagg
Journal:  Bioorg Med Chem       Date:  2008-12-03       Impact factor: 3.641

Review 9.  Discovery and development of heat shock protein 90 inhibitors.

Authors:  Tony Taldone; Weilin Sun; Gabriela Chiosis
Journal:  Bioorg Med Chem       Date:  2008-11-06       Impact factor: 3.641

Review 10.  Cancer and virus leads by HTS, chemical design and SEA data mining.

Authors:  Pahk Thepchatri; Jaeki Min; Thota Ganesh; Yuhong Du; Iestyn Lewis; Serdar Kurtkaya; Andrew Prussia; Lian Li; Blossom Sneed; Richard K Plemper; Haian Fu; Dennis C Liotta; James P Snyder; Raymond Dingledine; Aiming Sun
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.